Publication:
FDA’s Contradictory Decisions Related to the Delaney Clause

Thumbnail Image

Date

2011

Published Version

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Katheryn Klimko, FDA’s Contradictory Decisions Related to the Delaney Clause (May 2011).

Research Data

Abstract

This paper will focus on FDA regulation under the Delaney Clause, and particularly regulations that have led to contradictory results. It first will examine the history and basic requirements of the Delaney Clause. It next will discuss cancer: statistics regarding the frequency, types, and causes of cancer. Then it will examine some foods and food additives that have been associated with some level of carcinogenicity and how FDA has handled them. It will conclude by discussing the inherent problems that the Delaney Clause presents in establishing a uniform system of regulation and, finally, by proposing some potential alternative ways in which FDA might better use its power to help the public avoid excessive exposure to carcinogenic food substances.

Description

Other Available Sources

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories

Story
FDA's Contradictory Decisions Related to the… : DASH Story 2013-12-01
I am a professor of Toxicology at the University of Nebraska. I have been finding it difficult to find information related to the motivation leading to the Delaney Act prior to its enactment. This manuscript is providing me with key information both for my class and for a modern Toxicology book that I am writing. Much appreciated !